Amulet buys biopharma clinical trial company SynteractHCR

Healthcare private equity firm Amulet Capital Partners acquired SynteractHCR Holdings Corporation. Based outside San Diego, SynteractHCR is an international contract research organization that carries out Phase I-IV clinical trials for biopharmaceutical companies. Terms of the transaction were not disclosed.

DealsNorth AmericaUSBriefs